WELLINGBOROUGH, U.K.--A new report from InMedica (www.in-medica.com), on the world market for telehealth, forecasts that the number of gateways used in telehealth applications will increase to over one million in 2014 and to around 3.6 million in 2018. The initiatives taken by governments and private healthcare providers to increase reimbursements and reduce the legal and liability issues will help in the roll out of telehealth as a mainstream technology for remote disease and home-health monitoring.

“This gives a two to three year window for the current market barriers to be overcome, including demonstrating the benefits of telehealth on a large scale to health insurance companies.”

The US market for telehealth is likely to get a boost by the changes to healthcare provision being sought in “American Recovery and Re-investment Act” (ARRA), proposed policies that included: “Universal Healthcare Reform” summarised as i) provision of quality, affordable & portable health coverage for all, ii) modernising the US healthcare systems to reduce costs & improve quality, and iii) promoting prevention & strengthening public health. It is likely that the ARRA’s focus on finding more efficient methods to deliver medical service without increasing costs and resources will further boost the use of telehealth. InMedica predicts telehealth will start to be used by healthcare providers on a wider scale from 2012 onwards. According to Neha Khandelwal, market research analyst at InMedica “This gives a two to three year window for the current market barriers to be overcome, including demonstrating the benefits of telehealth on a large scale to health insurance companies.”

The new 174-page telehealth report, including Excel Tables and Figures, is available immediately.

The full press release pertaining to this new study, which contains substantial tabulated findings, can be found on our website.

About InMedica (a division of IMS Research)

InMedica is the medical research division of IMS Research, a specialist supplier of market research on a wide range of global electronics markets. The company is supported by headquarters in Wellingborough, UK and offices in Austin, Texas and Shanghai, China. InMedica regularly publishes detailed research on markets such as ultrasound and x-ray equipment, and consumer medical devices.